# Favorsun

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/favorsun

- Industry: Materials
- Headquarters: Suzhou, China
- Website: www.favorsun.com.cn
- Total disclosed funding: $14M
- Latest round: Series A (Aug 2, 2024)
- Investors on record: 2

## About

Based in Suzhou, China, and founded in 2020, Favorsun Medical Technology (Suzhou) Co., Ltd., trading as Favorsun, is a silk protein medical material developer that provides silk protein technology products. In June 2026, Favorsun raised a strategic investment from MF Capital, with participation from an individual investor.

The company takes silk fibroin as the core raw material and develops absorbable interface screws, silk fibroin degradable absorbable bone nails, 3D printed cartilage and other consumable products, it also developed and provided biological patches, skin wound repair membranes and other products.

The company generates revenue by selling silk protein technology products.

## Funding rounds

- Series A, Aug 2, 2024, $14M — Shaanxi Investment Fund Management, Yuhai Capital

## Investors

- Shaanxi Investment Fund Management (https://capitalatlas.ai/funds/shaanxi-investment-fund-management) — Series A
- Yuhai Capital (https://capitalatlas.ai/funds/yuhai-capital) — Series A